5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.12▼ | 9.15▼ | 9.14▼ | 9.34▼ | 9.30▼ |
MA10 | 9.15▼ | 9.19▼ | 9.31▼ | 9.67▼ | 8.58▲ |
MA20 | 9.17▼ | 9.34▼ | 9.43▼ | 9.53▼ | 7.18▲ |
MA50 | 9.40▼ | 9.67▼ | 9.77▼ | 8.57▲ | 6.47▲ |
MA100 | 9.70▼ | 9.81▼ | 9.65▼ | 7.21▲ | 6.41▲ |
MA200 | 9.80▼ | 9.26▼ | 8.89▲ | 6.77▲ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.005▲ | -0.019▼ | -0.029▼ | -0.150▼ | 0.286▲ |
RSI | 38.240▼ | 37.403▼ | 38.745▼ | 51.025▲ | 62.241▲ |
STOCH | 23.036 | 15.595▼ | 9.712▼ | 29.219 | 76.907 |
WILL %R | -74.286 | -95.109▼ | -95.109▼ | -80.729▼ | -26.271 |
CCI | -140.420▼ | -73.387 | -84.678 | -113.985▼ | 96.231 |
Thursday, August 07, 2025 01:58 PM
Elicio Therapeutics, Inc. ELTX) on Thursday reported a loss of $10.6 million in its second quarter. On a per-share basis, the Boston-based company said it had a loss of 66 cents.
|
Thursday, August 07, 2025 01:39 PM
Recent positive recommendation by the Independent Data Monitoring Committee (“IDMC”) to continue ELI-002 7P randomized Phase 2 study in pancreatic cancer without modifications to final analysis ...
|
Thursday, July 24, 2025 07:20 AM
Success of large-cap listings boosts IPO market outlook Nasdaq's second-quarter results beat Wall Street views Tariff tensions fuel market volatility, lifting trading volumes Nasdaq shares jump 7% ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
08/08/25 | 9.35 | 9.52 | 9.0612 | 9.20 | 24,817 |
07/08/25 | 8.9401 | 9.99 | 8.9401 | 9.07 | 35,383 |
06/08/25 | 9.30 | 9.61 | 9.30 | 9.37 | 14,114 |
05/08/25 | 10.20 | 10.27 | 8.83 | 9.14 | 66,998 |
04/08/25 | 9.7529 | 10.1717 | 9.7529 | 9.93 | 15,455 |
01/08/25 | 9.84 | 9.99 | 9.20 | 9.98 | 21,884 |
31/07/25 | 9.95 | 10.2071 | 9.75 | 9.81 | 19,070 |
30/07/25 | 10.25 | 10.75 | 9.83 | 9.925 | 76,220 |
29/07/25 | 10.40 | 10.40 | 9.8669 | 10.10 | 26,221 |
28/07/25 | 10.03 | 10.3999 | 9.825 | 10.14 | 37,882 |
|
|
||||
|
|
||||
|
|